SCHEMBL7523323

SCHEMBL7523323

CC(C)(C)c1ccc(O)c(C(C)(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.58
ESR2 Q92731 3/20 0.58
ALDH1A1 P00352 6/20 0.53
TDP1 Q9NUW8 2/20 0.53
ALOX15 P16050 2/20 0.53
HSD17B10 Q99714 2/20 0.53
HPGD P15428 1/20 0.53
CYP2D6 P10635 2/20 0.49
MAPT P10636 2/20 0.48
MEN1 O00255 2/20 0.48
GAA P10253 2/20 0.48
KMT2A Q03164 2/20 0.48
PKM P14618 1/20 0.48
RECQL P46063 1/20 0.48
HDAC4 P56524 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
TSHR P16473 3/20 0.45
CYP2C9 P11712 2/20 0.42
CYP3A4 P08684 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5596211 0.86 ALDH1A1 (0.50) ESR1ESR2ALDH1A1TDP1ALOX15
SCHEMBL11954771 0.85 ALDH1A1 (0.53) ESR1ESR2ALDH1A1TDP1ALOX15
SCHEMBL3895899 0.85 ALDH1A1 (0.53) ESR1ESR2ALDH1A1TDP1ALOX15
SCHEMBL11205966 0.85 ALDH1A1 (0.53) ESR1ESR2ALDH1A1TDP1ALOX15
SCHEMBL836617 0.85 ESR1 (0.68) ESR1ESR2ALDH1A1TDP1ALOX15
SCHEMBL29948246 0.85 ESR1 (0.68) ESR1ESR2ALDH1A1TDP1ALOX15
Benzene SCHEMBL28155736 0.84 ALDH1A1 (0.61) ESR1ESR2ALDH1A1TDP1ALOX15
SCHEMBL9815465 0.83 ALDH1A1 (0.59) ESR1ESR2ALDH1A1TDP1ALOX15
SCHEMBL7522926 0.82 ESR1 (0.50) ESR1ESR2ALDH1A1TDP1ALOX15
Biphenyl SCHEMBL28492519 0.81 ALDH1A1 (0.53) ESR1ESR2ALDH1A1TDP1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6489383-B1 SUCH AS 2-(2-HYDROXY-3-(1,1-DI(4-2-(BROMOETHOXY)PHENYL) ETHYL)-5-TERT-BUTYLPHENYL)-2H-BENZOTRIAZOLE FOR USE AS STOVING LACQUER, FINISHING ENAMEL FOR AUTOMOBILES CIBA SPECIALTY CHEMICALS CORPORATION 2002-12-03 US disclosed
US-20020169239-A1 2H-benzotriazole UV absorbers substituted with 1,1-diphenylakyl groups and compositions stabilized therewith WOOD MERVIN G (US) 2002-11-14 US disclosed
US-6392056-B1 FOR THERMOPLASTIC RESINS CIBA SPECIALTY CHEMICAL CORPORATION 2002-05-21 US disclosed
WO-2002012204-A1 2H-BENZOTRIAZOLE UV ABSORBERS SUBSTITUTED WITH 1,1-DIPHENYLALKYL GROUPS AND COMPOSITIONS STABILIZED THEREWITH CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020169239-A1 2H-benzotriazole UV absorbers substituted with 1,1-diphenylakyl groups and compositions stabilized therewith SUV39H1, SUV39H2, PAH ESR1 2850/4885ESR2 2462/4885ALDH1A1 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.